Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic agent of acute myeloid leukemia containing 1,3,7-trisubstituted 3,4-dihydropyrimido[4,5-D]pyrimidine-2(1H)-one derivatives

Therapeutic agent of acute myeloid leukemia containing 1,3,7-trisubstituted 3,4-dihydropyrimido[4,5-D]pyrimidine-2(1H)-one derivatives

US Patent 10155767 · Granted Dec 18, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyridinyltriazine derivative having protein kinase inhibitory activity, and phar2025
Pyridinyltriazine derivative having protein kinase inhibitory activity, and phar2025
Pyrimido[4,5-d]pyrimidin-2-one derivatives as protein kinase inhibitors2022
Multi-substituted pyrimidine derivatives with excellent kinase inhibitory activi2020
Anti-inflammatory 6-phenoxypyrimidine derivatives, process for their preparation2020
Substituted pyrimidine-4-carboxylic acids having anticancer activity2019
Substituted pyrimidine-4-carboxylic acids having anticancer activity2019
Substituted pyrimidine-4-carboxylic acids having anticancer activity2019
Substituted pyrimidine-4-carboxylic acids having anticancer activity2019
Substituted pyrimidine-4-carboxylic acids having anticancer activity2019
2,3,5-substituted thiophene compound as protein kinase inhibitor2019
2,3,5-substituted thiophene compound as protein kinase inhibitor2019